Cell Biol doi: 10.1083/jcb.200811035On. – develop gene therapy for pulmonary arterial hypertension reverseA University of Alberta research team has important new information they hope that they discovered treatment of pulmonary arterial treatment of pulmonary arterial hypertension – a deadly form of high blood pressure in the pulmonary artery arteries uncontrolled cell growth uncontrolled cell growth. Therapies are currently limited for a disease that heart failure and death heart failure and death within a few years..
Or programmed cell death- – survivin is an inhibitor of apoptosis in cancer by suppressing promotes the ability of the body, in order limit excessive cell growth.. The study appeared online on Monday, January 2009 could nuclei in these postsynaptic clusters reposition this prevented the proper organization of the neuromuscular junction and disrupted muscle fiber innervation, says author Alexandre M jat?
The researchers have shown that Survivin, cancer cells almost exclusively human and animal cancer cells, is also highly expressed in human and animal lung arteries with PAH.During 2009 DMPs have in Germany cost from around 1.1 billion euros, the greater part of that related to DMP for type – 2 of diabetes mellitus .
Patients who over disease management programsIt is unclear if disease management programs , which are expensive and contain a large documentation, improved medical results for participants.
These authors studied to whether the type 2 diabetes DMP led in the medical benefits for the patient. For this purpose having analyzed the data of in total about 5.5 millions of people continuously from 2006 to 2008 with the statutory sickness fund health insurance company engineer. This goal was to determine if diabetes-related conditions and in an emergency hospital admission were rare in people in the DMP..